NUclear MEdicine DIagnostic and Artificial Intelligence (NUMEDIA)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05963841 |
Recruitment Status :
Recruiting
First Posted : July 27, 2023
Last Update Posted : February 7, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Artificial intelligence algorithms for parathyroid adenoma detection in parathyroid scans The aim of the study is to develop programs for the automatic subtraction of planar and tomographic parathyroid images and for the localization of parathyroid adenomas using artificial intelligence tools.
Inclusion criteria Patients having undergone a double isotope parathyroid diagnostic examination using the standard Besançon University Hospital protocol (double injection of 123I and 99mTc, pinhole image, low energy high resolution (LEHR) and (single-photon emission tomography / Computed tomography) SPECT/CT +/- (positron emission tomography (PET) Choline).
Secondary endpoints Concordance between diagnoses made by nuclear physicians using both methods (current method and new treatment method).
Condition or disease | Intervention/treatment |
---|---|
Hyperparathyroidism | Device: treatment program |
Study Type : | Observational |
Estimated Enrollment : | 1 participants |
Observational Model: | Cohort |
Time Perspective: | Other |
Official Title: | Contribution to Disease Diagnosis and Prognosis Based on the Fusion of Expert Knowledge, Nuclear Medicine Imaging and Artificial Intelligence (AI) Tools |
Actual Study Start Date : | August 1, 2023 |
Estimated Primary Completion Date : | August 2026 |
Estimated Study Completion Date : | August 2027 |
- Device: treatment program
the study aims to set up an artificial intelligence diagnostic assistance programOther Name: diagnostic assistance program
- Development of an artificial intelligence diagnostic program [ Time Frame: through study completion, an average of 4 years ]Development of an artificial intelligence diagnostic program
- Development of an automatic program for subtracting double-isotope parathyroid images. [ Time Frame: through study completion, an average of 2 years ]Development of an automatic program for subtracting double-isotope parathyroid images.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Men and women over 18 years of age who underwent dual-isotope parathyroid scintigraphy.
- No refusal to use data for research purposes
- Retrospective data (after 13/04/2022: Date of posting of patient information in the department) and prospective data
Exclusion Criteria:
- Patient refusal to use data for research purposes
- Patients who did not benefit from the standard acquisition protocol (123I injection followed by 99mTc 3 hours after LEHR, PINHOLE and SPECT/CT acquisitions)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05963841
Contact: Laurent COMAS | 0381218477 | lcomas@chu-besancon.fr | |
Contact: Laurent COMAS | lcomas@chu-besancon.fr |
France | |
CHU Besancon | Recruiting |
Besançon, France, 25030 | |
Contact: Laurent COMAS 0381218477 lcomas@chu-besancon.fr |
Responsible Party: | Centre Hospitalier Universitaire de Besancon |
ClinicalTrials.gov Identifier: | NCT05963841 |
Other Study ID Numbers: |
2023/796 |
First Posted: | July 27, 2023 Key Record Dates |
Last Update Posted: | February 7, 2024 |
Last Verified: | July 2023 |
scintigraphy parathyroid SPECT/CT Intelligence artificial dual isotope |
Hyperparathyroidism Parathyroid Diseases Endocrine System Diseases |